Effect of roxithromycin on acute toxoplasmosis in mice - Wikidata - wikimedia - TriplyDB

Effect of roxithromycin on acute toxoplasmosis in mice

Effect of roxithromycin on acute toxoplasmosis in mice

http://www.wikidata.org/entity/Q35540929

about

In vitro and in vivo effects of doxycycline on Toxoplasma gondii In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection Human antiprotozoal therapy: past, present, and future.In vitro and in vivo activities of macrolides against Mycobacterium leprae Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.New antibacterials for the treatment of toxoplasmosis; a patent review.Clinical relevance of intracellular and extracellular concentrations of macrolides.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.

P2860

Q28335472-B7D785F0-7C08-4CFA-9042-6A54FB77E559 Q28359823-A8BD0E23-7E5D-4F50-8CEE-09D7ABC49A48 Q28359844-A8B04DB4-ADCB-43C0-B613-AC18D72BF05B Q28369142-C9AB2F3A-17C3-4C04-8649-354979E939E8 Q28379168-B2FB19BD-CDA2-4A40-8A3E-C6AE5603E5A2 Q35535171-E7609710-D663-459D-AFBB-3E02F9F8D81B Q35565659-E2050F14-CBA0-4F42-B5E1-631056951832 Q36753766-DFC0065C-6306-45A3-87DE-A3AFCD3912C2 Q37992089-15176525-ED63-485E-A3A7-92A55E17B5F9 Q40545419-14AE1325-C350-4AF0-9020-6FA3F4F75FA8 Q40865388-2E7ACA97-8219-4DD7-A57D-D7524B68983F Q41000192-533C9D10-ABEA-4A29-BDE7-1FAB18A9891C

P2860

Effect of roxithromycin on acute toxoplasmosis in mice

http://www.wikidata.org/entity/Q35540929

description

1987 nî lūn-bûn

@nan

1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Effect of roxithromycin on acute toxoplasmosis in mice

@ast

Effect of roxithromycin on acute toxoplasmosis in mice

@en

type

label

Effect of roxithromycin on acute toxoplasmosis in mice

@ast

Effect of roxithromycin on acute toxoplasmosis in mice

@en

prefLabel

Effect of roxithromycin on acute toxoplasmosis in mice

@ast

Effect of roxithromycin on acute toxoplasmosis in mice

@en

P1433

Q35540929-5D90695A-D433-4ACE-A559-ED024A4641B0

P1476

Q35540929-BBD32C6F-0341-4E97-A70E-BE417197E9C9

P2093

Q35540929-A2A6FD88-E358-4366-81DE-DC88CEAB5450

Q35540929-C8100B14-E750-42CE-8D55-A83F77376799

P2860

Q35540929-0B42BCA0-894A-417E-9E11-77870EBC7E04

Q35540929-4173F0A4-2766-4C13-8D5B-91906EB64FCB

Q35540929-4CF966F3-AEBE-48F0-8598-9111A948A788

Q35540929-6F5A8802-B161-4368-9B02-71AB8FF9293B

Q35540929-98540BEE-D05B-48C3-995E-C84D82302B42

Q35540929-B1D1B34D-84D1-485F-9F23-D4A13D1AA279

Q35540929-BE37C403-807E-4E08-9175-B8F225F0D046

Q35540929-F0DE4455-7F8F-43D6-A7EB-2272AE280C25

P304

Q35540929-C6F95CA1-0C7A-480C-A8C0-9A81A78679F4

P31

Q35540929-4C5CD2EA-B45F-43EC-B18F-A97D56251F47

P356

Q35540929-892D14F1-ACCF-48BF-84A0-5F0448BD9568

P407

Q35540929-36C0C721-27B6-46DE-85FD-E849BC26576F

P433

Q35540929-D87CD7CD-DE1F-4D5E-9F61-E7859C6618E8

P478

Q35540929-FFDBF2FE-9563-4619-9AB9-DFC34E29A744

P577

Q35540929-E9B5AC88-D65C-4E01-BB01-22C37EEC9EDC

P5875

Q35540929-E7798058-BE9C-4BF4-BBDE-3D3DE37C928A

P698

Q35540929-9B0AF8AE-093B-43DE-A701-C78385795706

P921

Q35540929-31EAACFF-C12E-4B89-9C8F-4ECFD542474A

P932

Q35540929-3DD60728-96C5-4632-B880-BABB2448B45B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Effect of roxithromycin on acute toxoplasmosis in mice

@en

P2093

Chang HR

http://www.w3.org/2001/XMLSchema#string

Pechere JC

http://www.w3.org/2001/XMLSchema#string

P2860

[Spiramycin therapy of experimental toxoplasmosis in mice.]

Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro

Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.

In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms.

P304

1147-1149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.7.1147

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19498410

http://www.w3.org/2001/XMLSchema#string

P698

3662475

http://www.w3.org/2001/XMLSchema#string

P921

P932

174888

http://www.w3.org/2001/XMLSchema#string